Literature DB >> 17205885

Cefazolin induced seizures in hemodialysis patients.

Wiwat Arkaravichien1, Janyarat Tamungklang, Tarinee Arkaravichien.   

Abstract

Cephalosporins are epileptogenic drugs, especially when excessive dosages are used or when the drugs are used in patients with decreased renal clearance. The present case report showed that a chronic kidney patient receiving hemodialysis developed generalized tonic clonic seizures when an inappropriate high dose cefazolin was given. Cefazolin 2 g iv q 8 h was given for 25 days continuously to treat fever of unknown origin in a patient who was a severe renal impairment patient. In a severe renal impairment patient, the maintenance dose of cefazolin should be reduced by half and the interval for administration should be extended to 24 h. Even though hemodialysis could remove cefazolin from the blood circulation, in the presented case the very high dose of cefazolin given was far beyond the ability of hemodialysis to clear the drug. The accumulation ofcefazolin, therefore, induced three episodes of seizures on days 14, 21 and 25. More precaution should be taken when prescribing medication to a patient with predisposing factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17205885

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  3 in total

1.  What Should Be Considered to Cause the Early Post-Craniotomy Seizure: Antibiotics (Cefazolin) Irrigation.

Authors:  Ji Hwan Jang; Kyung Sun Song; Jae Seung Bang; Chang Wan Oh; O-Ki Kwon; Young Seob Chung
Journal:  J Korean Neurosurg Soc       Date:  2015-11-30

2.  Nonconvulsive status epilepticus cases arising in connection with cephalosporins.

Authors:  Ibrahim Bora; Aylin Bican Demir; Pinar Uzun
Journal:  Epilepsy Behav Case Rep       Date:  2016-05-20

3.  Paradoxical Anticonvulsant Effect of Cefepime in the Pentylenetetrazole Model of Seizures in Rats.

Authors:  Dmitry V Amakhin; Ilya V Smolensky; Elena B Soboleva; Aleksey V Zaitsev
Journal:  Pharmaceuticals (Basel)       Date:  2020-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.